Cooper C. Collins, Chief Strategic Officer, 10% Owner at PERNIX THERAPEUTICS HOLDINGS, INC. (PTX), sold 62,038 shares at $2.46 ($146K) on 2014-01-02, disclosed to the SEC on 2014-01-06.
Scheduled sale ($146k) by Chief Strategic Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.46 | 27,400 | $67K | 46.2% |
| 2 | $2.42 | 6,195 | $15K | 10.3% |
| 3 | $2.23 | 28,443 | $63K | 43.5% |
| Total | $2.35 avg | 62,038 | $146K | 100% |
| Filing → |
| TXMD | BUY | 2021-11-22 | $580K | — | Filing → |
| TXMD | BUY | 2021-08-19 | $725K | — | Filing → |
| TXMD | BUY | 2020-06-10 | $107K | — | Filing → |